Cargando…
A Prospective, Randomized Open-Label Study for Assessment of Antihypertensive Effect of Telmisartan Versus Cilnidipine Using Ambulatory Blood Pressure Monitoring (START ABPM Study)
BACKGROUND: The antihypertensive agent telmisartan is an angiotensin II receptor blocker with a terminal elimination half-life of 24 h and has a high lipophilicity, thereby enhancing its bioavailability. Another antihypertensive agent, cilnidipine is a calcium antagonist and has dual mode of action...
Autores principales: | Sawant, Rahul, Suryawanshi, Sachin, Jadhav, Mayur, Barkate, Hanmant, Bhushan, Sumit, Rane, Tanmay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257498/ https://www.ncbi.nlm.nih.gov/pubmed/37304922 http://dx.doi.org/10.14740/cr1476 |
Ejemplares similares
-
Retrospective Study to Assess the Effect of Telmisartan on Urine Albumin to Creatinine Ratio in Indian Hypertensive Patients
por: Sharma, Balram, et al.
Publicado: (2021) -
Impact on Hypertension Reclassification by Ambulatory Blood Pressure
Monitoring (ABPM) according to the V Brazilian Guidelines on
ABPM
por: Grezzana, Guilherme Brasil, et al.
Publicado: (2013) -
Usefulness of ambulatory blood pressure measurement for hypertension management in India: the India ABPM study
por: Kaul, Upendra, et al.
Publicado: (2019) -
Normality thresholds for ambulatory blood pressure monitoring (ABPM) in the European, American and Brazilian guidelines: is there a need for revision?
por: Silva, Ricardo Pereira, et al.
Publicado: (2022) -
Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: A prospective study
por: Adake, Prabhakar, et al.
Publicado: (2015)